Neko secures $700m Series C funding, surpassing 100k members and achieving clinic-level profitability
Executive summary: Neko announced a $700 million Series C round, revealing it has reached 100,000 members and is profitable at the clinic level. The funding validates Neko’s business model, provides resources for rapid geographic and service expansion, and signals strong market demand for preventive health solutions.
Who is involved: Neko’s leadership and existing investors participated in the Series C; the news was reported by Sifted.
Likely next: Neko will allocate the proceeds to open additional clinics, enhance its technology platform, and pursue further member growth targets in the EU.
Neko’s latest financing round values the preventive health platform at a new high, underscoring strong investor confidence in its profitable clinic-level operations. The company reports 100,000 members, indicating rapid adoption of its health screening services across Europe. This combination of sizable capital and early profitability positions Neko to expand its footprint while prompting competitors to reassess their own growth strategies.
Timeline
- — Neko raises $700m Series C: ‘We now have 100k members and are profitable at clinic level’ (Sifted — EU startups)
Key entities
Sources
- Neko raises $700m Series C: ‘We now have 100k members and are profitable at clinic level’ — Sifted — EU startups
Related cases
- Helcim secures $53M Series C to capitalize on banks' retreat from small‑business payments, boosting its valuation to $250M CAD
- Moss fintech achieves unicorn status with €30m Series C, signaling strong VC confidence in German fintech
- German expense‑management fintech Moss reaches unicorn status after a €30 million Series C, signalling continued investor appetite for European B2B SaaS scale‑ups
- Moa Technology secures £22.2 million Series C funding to advance its novel mode-of-action herbicide pipeline